StrategyStates Move Ahead With Canada Drug Importation While Awaiting Signal From Biden
The Pharmaceutical Research and Manufacturers of America, an industry trade group, filed suit in federal court in Washington, D.C., to...
Revenue CycleAHA: CMS Should Reconsider Most Favored Nation Model
The rule places financial burden on provider organizations and forces them to divert resources to purchase drugs necessary for patient...
StrategySan Francisco Wrestles With Drug Approach as Death and Chaos Engulf Tenderloin
San Francisco is on track to lose an average of nearly two people a day to drugs in 2020, compared...
InnovationLifeBridge Uses COVID-19 Vaccine App to Manage Complex Scheduling and Communications Processes
The GetWellNetwork tool offers a method to relieve overburdened workers and boost compliance rates among vaccine recipients.
Revenue CycleCMS Clarifies Use of New Condition Codes 90 and 91
The National Uniform Billing Committee (NUBC) recently created the condition codes for use on healthcare claims, effective February 1, 2021.
FinancePharmaceutical Payments to Physicians Associated with Increased Prescribing
The research indicated that the findings were "consistent across all studies," adding that the pharmaceutical-physician association caused doctors to prescribe...
StrategySurprise Federal Drug Rule Directs Insurers to Reveal What They Pay for Prescription Drugs
The drug price provisions, which would not begin until 2022, were a surprise because they were not included in the...
StrategyPatients Struggle to Find Prescription Opioids After NY Tax Drives Out Suppliers
Pain patients in New York have lost access to vital medicine since July 2019, when the state implemented an excise...
Clinical CareFewer Physicians Accepting Industry Payments, But Payment Values Stay Steady
A new study highlights the importance of tracking physician conflicts of interest.
Finance17 States Have Implemented or Explored Prescription Drug Affordability Review Boards
A new report from Manatt Health reviews the "current legislative landscape pertaining to" drug affordability review boards.
StrategyDrug Lobby Rips Trump's 'Most Favored Nation' Mandate on Medicare Drug Prices
PhRMA says the White House has "doubled down on a reckless attack on the very companies working around the clock...
Clinical CareMany Hospitals Still Don't Have Drug Diversion Programs
CDC information shows the increase in the frequency of disease outbreaks stemming from drug diversion.